On Wednesday, Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported third-quarter adjusted EPS of $1.74, up from $1.65 a year ago, in line with the Street estimates. The orthopedic giant reported sales of ...
Zimmer Biomet shows value with new products and M&A, but execution risks remain. Click here to read my latest analysis of ZBH ...
WARSAW, Ind. (Inside INdiana Business) — The U.S. Food and Drug Administration has authorized a “smart knee” implant developed by Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) and Canary ...
(RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH) announced FDA De Novo classification grant and authorization to market the tibial extension for Persona IQ Knee Implant which allows surgeons to monitor ...
Total knee replacement surgery just got a bit of an IQ boost. The FDA offered up a de novo clearance for Zimmer Biomet and Canary Medical’s Persona IQ system, marking it as the first “smart” knee ...
Please provide your email address to receive an email when new articles are posted on . Zimmer Biomet received FDA premarket approval for its Oxford cementless partial knee replacement implant. The ...
Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported first-quarter adjusted EPS of $1.81, down from $1.94 a year ago, beating the Street estimates of $1.77. The orthopedic giant reported sales of $1.91 ...
"For younger and more active patients, the Oxford Cementless Partial Knee amplifies the benefits of a traditional partial knee replacement by offering knee flexion that resembles natural knee movement ...
Noblesville-based Indiana Orthopedic Institute is an early adopter of a “cementless” partial knee replacement system recently launched in the United States but has long been used in Europe and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback